Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pierson Ferdinand is an international, technology-driven law firm launched in early 2024 with over 130 partners and more than 80 practice areas. The firm's expertise includes intellectual property (IP), patent prosecution, healthcare and pharmacy law, regulatory counsel for pharmaceutical and biotechnology companies, and complex commercial litigation. Its attorneys have deep experience advising clients across the life sciences sector—including biotech, pharma, medtech—and provide strategic IP counseling from early-stage innovation through commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pierson Ferdinand.